Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Trizuljak, Jakub; Sperr, Wolfgang; Nekvindova, Lucie; Elberink, Hanneke; Gleixner, Karoline; Gorska, Aleksandra; Lange, Magdalena; Hartmann, Karin; Illerhaus, Anja; Bonifacio, Massimiliano; Perkins, Cecelia; Elena, Chiara; Malcovati, Luca; Fortina, Anna; Shoumariyeh, Khalid; Jawhar, Mohamad; Zanotti, Roberta; Bonadonna, Patrizia; Caroppo, Francesca; Zink, Alexander; Triggiani, Massimo; Parente, Roberta; von Bubnoff, Nikolas; Yavuz, Akif; Hagglund, Hans; Mattsson, Mattias; Panse, Jens; Jaekel, Nadja; Kilbertus, Alex; Hermine, Olivier; Arock, Michel; Fuchs, David; Sabato, Vito; Brockow, Knut; Bretterklieber, Agnes; Niedoszytko, Marek; van Anrooij, Bjorn; Reiter, Andreas; Gotlib, Jason; Kluin-Nelemans, Hanneke; Mayer, Jiri; Doubek, Michael; Valent, Peter

doi:10.1111/all.14248

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Copy For Citation

Trizuljak J., Sperr W. R., Nekvindova L., Elberink H. O., Gleixner K., Gorska A., ...More

ALLERGY, vol.75, no.8, pp.1927-1938, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 75 Issue: 8
Publication Date: 2020
Doi Number: 10.1111/all.14248
Journal Name: ALLERGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
Page Numbers: pp.1927-1938
Istanbul University Affiliated: No

Abstract

Background: In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable to that of cutaneous mastocytosis (CM). The aim of this project was to compare the prognosis of patients with ISM with that of patients with CM.